Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Federaal Kenniscentrum voor Gezondheidszorg, Belgium | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Prematurity remains the main cause of death and serious health problems in new-borns. Besides the need for hospitalization and medical interventions in the first weeks or months of the new-borns' life, prematurity can cause long-lasting health problems (e.g. multiple hospital admissions, developmental delay, learning difficulties, motor delay, hearing or eye problems, ...). Moreover, prematurity places an enormous economic burden on the society. Aside from the medical problems and the financial cost, the emotional stress and psychological impact on the parents, siblings and other family members should not be underestimated.
Previous preterm delivery (before 37 weeks of pregnancy) increases the risk for recurrent preterm delivery in a subsequent pregnancy. Therefore, these women should be considered as 'high risk' for preterm birth.
Infections ascending from the vagina may be an important cause of preterm delivery in certain cases. Some women have an abnormal vaginal microbiome and are therefore at risk for infections and preterm birth. On the other hand, the vaginal flora is more stable and resistant to infections in healthy pregnant women who deliver at term (after 37 weeks of gestation).
Synbiotics are a mixture containing probiotics and prebiotics. Probiotics are living bacteria with potential beneficial effects that can be used safely in pregnancy, while prebiotics are consumed by the bacteria. It is known that probiotics, when used for a long period of time, can maintain a healthy and stable vaginal flora that may protect against infections. In this study, pregnant patients with a history of preterm birth will be included in the first trimester of pregnancy to start with synbiotics or placebo. The investigators will examine the effect of synbiotics on the vaginal flora and on the pregnancy duration. The hypothesis is that synbiotics, when started early in the pregnancy, can change the disturbed vaginal flora into a stable micro-environment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Synbiotics | Experimental | Oral synbiotic (food supplement) containing 8 probiotic Lactobacillus strains, the prebiotics inulin, fructooligosaccharides (FOS) and D-mannose. |
|
| Placebo | Placebo Comparator | Matching placebo |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Synbiotics | Other | Oral synbiotic (food supplement) containing 8 probiotic Lactobacillus strains, the prebiotics inulin, fructooligosaccharides (FOS) and D-mannose. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Gestational age at delivery | Through study completion - at delivery |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of PTB, defined as GA at delivery < 37 weeks | Through study completion - at delivery | |
| Proportion of PTB in different categories |
|
| Measure | Description | Time Frame |
|---|---|---|
| Effect of antibiotics on the vaginal microbiome | When the patient is admitted in case the pregnancy was complicated with PPROM | During pregnancy until 28 days after PPROM |
| Effect on the gastrointestinal microbiome of the neonate in case of PPROM |
Inclusion Criteria:
Signed written informed consent must be obtained before any study assessment is performed;
18 years of age or older;
Singleton pregnancy;
Pregnancy consultation between 8 and 10 weeks gestation.
At least one of the following risk factors for spontaneous preterm birth:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Caroline Van Holsbeke, PhD | Contact | 003289804057 | Caroline.van.holsbeke@zol.be | |
| Katrien Nulens, MD | Contact | 003289804125 | Katrien_Nulens@hotmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universitaire Ziekenhuis Antwerpen | Recruiting | Edegem | Antwerpen | 2650 | Belgium |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39289685 | Derived | Nulens K, Papy E, Tartaglia K, Dehaene I, Logghe H, Van Keirsbilck J, Chantraine F, Masson V, Simoens E, Gysemans W, Bruckers L, Lebeer S, Allonsius CN, Oerlemans E, Steensels D, Reynders M, Timmerman D, Devlieger R, Van Holsbeke C. Synbiotics in patients at risk for spontaneous preterm birth: protocol for a multi-centre, double-blind, randomised placebo-controlled trial (PRIORI). Trials. 2024 Sep 17;25(1):615. doi: 10.1186/s13063-024-08444-8. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D047928 | Premature Birth |
| D003141 | Communicable Diseases |
| ID | Term |
|---|---|
| D007752 | Obstetric Labor, Premature |
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
| ID | Term |
|---|---|
| D058616 | Synbiotics |
| ID | Term |
|---|---|
| D056692 | Prebiotics |
| D019587 | Dietary Supplements |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Other | Matching placebo |
|
| Through study completion - at delivery |
| PPROM | Incidence | Up to 34 weeks from the date of randomization |
| PPROM | Gestational age at PPROM | Up to 34 weeks from the date of randomization |
| PPROM | Time to delivery | Up to 34 weeks from the date of randomization |
| Composition of the vaginal microbiome | The vaginal microbiome will be assessed throughout pregnancy at 4 well-defined stages of pregnancy (9, 20, 30 weeks and at delivery) and at admission at the MIC unit for preterm labor, PPROM or cervical insufficiency. | Assessed 3 times during the study period: at randomization, 11-13 weeks after randomization (at gestational age 19-21 weeks), and 21-23 weeks after randomization (29-31 weeks of gestation) |
| Incidence of neonatal admissions | Neonatal admission at a neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Duration of neonatal admissions | Neonatal admission at a neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Incidence of maternal admissions | Up to 34 weeks from the date of randomization |
| Duration of maternal admissions | Up to 34 weeks from the date of randomization |
| Quality Of Life during pregnancy and during neonatal admission at a neonatal intensive care unit | Using EQ5D questionnaire (5 questions and scale from 1 to 100) | Trough study completion, on average 1 year |
| Neonatal outcome: infectious parameters | Sepsis (early, late and culture negative), number of episodes (min 72 hours) of antibiotic treatment, duration of antibiotic treatment in days | During the admission at the neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Neonatal outcome: bronchopulmonary dysplasia (BPD) | Proportion of each category (no, mild, moderate and severe) | During the admission at the neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Neonatal outcome: intraventricular haemorrhage | Incidence | During the admission at the neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Neonatal outcome: periventricular leukomalacia | Incidence | During the admission at the neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Neonatal outcome: respiratory support | Need for respiratory support (CPAP: continuous positive airways pressure, non-invasive positive pressure ventilation or mechanical endotracheal ventilation) and the duration of respiratory support in days. Use and administration of surfactant | During the admission at the neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Neonatal outcome: retinopathy | Incidence | During the admission at the neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Neonatal outcome: neonatal morbidity | Incidence | During the admission at the neonatal intensive care unit (when the neonate is admitted at a neonatal intensive care unit within 7 days of delivery) |
| Neonatal outcome: birth weight | After the neonate is born |
When the neonate is born after a pregnancy complicated with PPROM
| Between 13 to 36 weeks from the date of randomization |
| Placental microbiome in case of preterm birth | In case the pregnancy was complicated with preterm birth (delivery before 37 weeks of gestation) | Between 13 to 36 weeks from the date of randomization |
| Ziekenhuis Oost-Limburg | Recruiting | Genk | Limburg | 3600 | Belgium |
|
| Universitaire Ziekenhuizen Leuven | Recruiting | Leuven | Limburg | 3000 | Belgium |
|
| CHR Citadelle | Recruiting | Liège | Liège | 4000 | Belgium |
|
| UZ Gent | Recruiting | Ghent | Oost-Vlaanderen | 9000 | Belgium |
|
| AZ Sint-Jan | Recruiting | Bruges | West-Vlaanderen | 8300 | Belgium |
|
| AZ Sint-Lucas | Recruiting | Bruges | West-Vlaanderen | 8310 | Belgium |
|
| AZ Maria Middelares | Recruiting | Ghent | West-Vlaanderen | 9000 | Belgium |
|
| AZ Groeninge | Recruiting | Kortrijk | 8500 | Belgium |
|
| D000091642 | Urogenital Diseases |
| D007239 | Infections |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010829 |
| Physiological Phenomena |
| D019936 | Probiotics |
| D019602 | Food and Beverages |